Clinical trial

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

NCT02988960

Study summary

ClinicalTrials.gov

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention ABBV-927 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention ABBV-181 Find medicine records · Find other trials using this name

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2017-02-22

PhasePHASE1

Conditions

Advanced Solid Tumors Cancerunresolved

Interventions

ABBV-927DRUG

ABBV-181DRUG

Sponsors & collaborators

AbbVielead sponsor

Mapped research locations

MadridSpain2 HoustonTexas, United States1 BostonMassachusetts, United States1 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 TorontoOntario, Canada1 NashvilleTennessee, United States1 SeoulSouth Korea1 ValenciaSpain1 FairfaxVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02988960 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.